Clinical Trial Update: Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil [Phase 1]

View source ↗

Summary

Phase 1 trial update reports pharmacokinetics and safety/tolerability of YY-201 compared with dutasteride and tadalafil in men with benign prostatic hyperplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• TADALAFIL (TADALAFIL)
• YY-201

Snippet

Sponsor: Yuyu Pharma, Inc. | Conditions: Benign Prostatic Hyperplasia | Phase 1 | Status: COMPLETED